Wuhan Boster Biological Technology Co., Ltd.
Biotechnology and laboratory services · Wuhan, Hubei
About Wuhan Boster Biological Technology Co., Ltd.
Wuhan Boster Biological Technology Co., Ltd. is a biotechnology company founded in 1993 in Wuhan, Hubei, specialised in the research, development and manufacture of research antibodies and ELISA kits. From its site in the Optics Valley Biopharmaceutical Accelerator, in the East Lake High-Tech Development Zone, it serves — according to its official website — more than 10,000 research institutions around the world.
Its catalogue covers more than 20,000 antibody targets and over 2,000 ELISA product lines, spanning primary antibodies for Western blot, immunohistochemistry and flow cytometry, ELISA kits with high sensitivity up to picogram levels, recombinant proteins and reagents for cell culture and protein detection. The company's products are cited, by its own count, in more than 80,000 scientific publications.
Boster combines own-brand manufacturing in Wuhan with an international presence — its US-facing brand operates from California — and distributors in dozens of countries. For laboratories it also offers custom antibody generation and bulk formats, positioning itself as a Chinese alternative to the major Western reagent suppliers.
Its catalogue covers more than 20,000 antibody targets and over 2,000 ELISA product lines, spanning primary antibodies for Western blot, immunohistochemistry and flow cytometry, ELISA kits with high sensitivity up to picogram levels, recombinant proteins and reagents for cell culture and protein detection. The company's products are cited, by its own count, in more than 80,000 scientific publications.
Boster combines own-brand manufacturing in Wuhan with an international presence — its US-facing brand operates from California — and distributors in dozens of countries. For laboratories it also offers custom antibody generation and bulk formats, positioning itself as a Chinese alternative to the major Western reagent suppliers.